UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
March 23, 2018 20:43 ET
|
CURE Pharmaceutical
LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will...
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
March 23, 2018 11:00 ET
|
CURE Pharmaceutical
LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will...
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board
June 27, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...